HORMONAL TREATMENTS FOR BREAST CANCER (ALL
drug has been approved by the FDA (Food and Drug
Administration) for the treatment of metastatic
(Stage IV) breast cancer.
mg (1 tablet) per day.
|Duration and timing:
In the treatment of stage IV disease treatment is
continued until disease progression.
possible nausea and vomiting (which may
be decreased or prevented with
medications), abdominal pain,
constipation, diarrhea, loss of appetite.
menopausal symptoms (hot
flashes, night sweats, menstrual
irregularity), bone or tumor pain.
adverse effect on fertility is known;
this drug should not be taken by women
who are pregnant or breast feeding.
instances of pulmonary embolism have
occurred (blood clot going to the lung),
dyspnea (feeling of shortness of breath),
cough and pharyngitis.
increased risk of developing blood clots,
edema, dizziness, headaches, depression,
rash and generalized weakness have all
1997 - TransMed Network